HUE052700T2 - Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitással - Google Patents
Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitássalInfo
- Publication number
- HUE052700T2 HUE052700T2 HUE17759330A HUE17759330A HUE052700T2 HU E052700 T2 HUE052700 T2 HU E052700T2 HU E17759330 A HUE17759330 A HU E17759330A HU E17759330 A HUE17759330 A HU E17759330A HU E052700 T2 HUE052700 T2 HU E052700T2
- Authority
- HU
- Hungary
- Prior art keywords
- substituted
- acid derivatives
- neuroprotective activity
- novel types
- improved neuroprotective
- Prior art date
Links
- HCZHHEIFKROPDY-UHFFFAOYSA-N kynurenic acid Chemical class C1=CC=C2NC(C(=O)O)=CC(=O)C2=C1 HCZHHEIFKROPDY-UHFFFAOYSA-N 0.000 title 1
- 230000000324 neuroprotective effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1600179A HUP1600179A2 (hu) | 2016-03-04 | 2016-03-04 | Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitással |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE052700T2 true HUE052700T2 (hu) | 2021-05-28 |
Family
ID=89992110
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1600179A HUP1600179A2 (hu) | 2016-03-04 | 2016-03-04 | Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitással |
| HUE17759330A HUE052700T2 (hu) | 2016-03-04 | 2017-03-03 | Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitással |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU1600179A HUP1600179A2 (hu) | 2016-03-04 | 2016-03-04 | Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitással |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10870633B2 (hu) |
| EP (1) | EP3423444B1 (hu) |
| HU (2) | HUP1600179A2 (hu) |
| WO (1) | WO2017149333A1 (hu) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US881282A (en) * | 1906-10-06 | 1908-03-10 | Charles C Armstrong | Window or like screen. |
| GB8719102D0 (en) | 1987-08-12 | 1987-09-16 | Merck Sharp & Dohme | Therapeutic agents |
| FR2827599A1 (fr) * | 2001-07-20 | 2003-01-24 | Neuro3D | Composes derives de quinoleine et quinoxaline,preparation et utilisations |
| HU226977B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them |
| HUP0700051A2 (en) * | 2007-01-17 | 2008-09-29 | Univ Szegedi | Use of kynurenic acid and derivatives there of for treating of gastrointestinal disorders associated with enhanced motility and inflammation |
| HUP0900281A2 (hu) | 2009-05-05 | 2011-01-28 | Univ Szegedi | Kinurénsav-származékok, eljárás a vegyületek elõállítására, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk fejfájás kezelésére |
| HU230366B1 (hu) | 2010-06-29 | 2016-03-29 | Szegedi Tudományegyetem | Kinurénsavamid származékok alkalmazása Huntington-kór kezelésére |
-
2016
- 2016-03-04 HU HU1600179A patent/HUP1600179A2/hu unknown
-
2017
- 2017-03-03 US US16/082,099 patent/US10870633B2/en active Active
- 2017-03-03 EP EP17759330.8A patent/EP3423444B1/en active Active
- 2017-03-03 WO PCT/HU2017/000014 patent/WO2017149333A1/en active Application Filing
- 2017-03-03 HU HUE17759330A patent/HUE052700T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3423444A4 (en) | 2019-09-11 |
| EP3423444B1 (en) | 2020-11-18 |
| US20190106409A1 (en) | 2019-04-11 |
| US10870633B2 (en) | 2020-12-22 |
| EP3423444A1 (en) | 2019-01-09 |
| HUP1600179A2 (hu) | 2017-09-28 |
| WO2017149333A1 (en) | 2017-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201704557B (en) | Use of picolinamide compounds with fungicidal activity | |
| ZA201704559B (en) | Use of picolinamide compounds with fungicidal activity | |
| HK1254057A1 (zh) | 用於製備膽汁酸衍生物的方法和中間體 | |
| EP3318465A4 (en) | Baby wagon with improved ease of use | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| HK1254055A1 (zh) | 製備奧貝膽酸及其衍生物的方法 | |
| IL263050B (en) | History of Subtirum | |
| EP3330256A4 (en) | Heterocyclic derivatives with TRKA-inhibiting activity | |
| EP3187492A4 (en) | Pyrimidinone derivative having autotaxin-inhibitory activity | |
| IL249511A0 (en) | Novel p450-bm3 variants with enhanced activity | |
| IL257223A (en) | New crystalline form and acetic acid adducts of palbociclib | |
| HK1232220A1 (zh) | 用於治療心血管疾病的 -苄基異喹啉衍生物 | |
| EP3229814A4 (en) | Co-crystal of dapagliflozin with citric acid | |
| EP3261631A4 (en) | INHIBITION OF OLIG2 ACTIVITY | |
| DK3200779T3 (en) | Novel anthranilic acid derivatives | |
| IL256441B (en) | New p450–bm3 variants with enhanced activity | |
| HUE064755T2 (hu) | Alfa-halo-akrilsav-származékok átmenetifém-katalizált protodekarboxilezõdése | |
| PL2997144T3 (pl) | Kompozycje enzymów do poprawy procesów fermentacji i ich produktów ubocznych | |
| IL259073A (en) | History of abscisic acid - converted at the 3' position | |
| PT3454674T (pt) | Métodos de uso da fórmula infantil fermentada | |
| EP3337479A4 (en) | NOVEL POLYMORPH OF DOLUTEGRAVIR AND SALTS FROM IT | |
| IL275127A (en) | Glycosidic antecedents of treprostinil | |
| HUE052700T2 (hu) | Új típusú C-3 szubsztituált kinurénsavszármazékok hatékonyabb neuroprotektív aktivitással | |
| PT3395819T (pt) | Forma cristalina de derivado de aminopirano substituído | |
| EP3372235A4 (en) | AMPLIFIER OF ACTIVITY AGAINST DAMAGE OF ROYAL JELLY |